Recurrent Melanoma Completed Phase 1 / 2 Trials for Methionine (DB00134)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs